Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,660.00
-90.00 (-3.27%)
At close: Oct 8, 2026

Aligned Genetics Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11,43814,61810,13914,92710,6966,137
Short-Term Investments
4,000-7,500-3,0007,000
Cash & Short-Term Investments
15,43814,61817,63914,92713,69613,137
Cash Growth
-9.21%-17.13%18.17%8.99%4.25%8.22%
Accounts Receivable
2,8062,6232,8552,6671,4512,130
Other Receivables
269.19395.5196.3755.6417.55293.91
Receivables
3,1363,0793,3312,7231,4692,424
Inventory
5,4474,9844,1983,8523,7592,353
Prepaid Expenses
380.85100.58130.0713.01343.1158.1
Other Current Assets
419.2839.95268.188.1284.98413.05
Total Current Assets
24,82122,82225,56721,60319,55218,386
Property, Plant & Equipment
20,30919,8357,7708,0357,2855,776
Long-Term Investments
7,3667,8808,0588,5847,2337,744
Other Intangible Assets
236.52202.04131.5331.0364.35101.08
Long-Term Deferred Tax Assets
2,8732,1941,8422,0642,0431,780
Long-Term Deferred Charges
-----0
Other Long-Term Assets
4,7584,801858.17600.51723.89683.35
Total Assets
60,43957,79544,27540,93236,90134,469

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
128.1153.797.48164.9134.26144.46
Accrued Expenses
363.59365.33234.02130.05277.79150.37
Current Portion of Long-Term Debt
2,5202,520-3,900--
Current Portion of Leases
180.0948.32173.94175.47235.32214.76
Current Income Taxes Payable
5.6619.0979.8877.487.32-
Current Unearned Revenue
---9.86--
Other Current Liabilities
1,3751,3841,311780.35598.52907.73
Total Current Liabilities
4,5724,4901,8965,2381,3331,417
Long-Term Debt
11,79011,8502,400-3,9003,900
Long-Term Leases
477.8686.35389.6587.61243.97320.97
Pension & Post-Retirement Benefits
4,0243,9073,7603,5102,4221,741
Long-Term Deferred Tax Liabilities
5.14.75----
Other Long-Term Liabilities
365.8295.8335.45284.31152.4998.52
Total Liabilities
21,23520,6338,7819,6208,0527,477

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,1897,1897,1897,1893,5953,595
Additional Paid-In Capital
22,64622,64622,64622,64626,25926,259
Retained Earnings
10,6368,9685,8511,680-1,202-2,936
Treasury Stock
--997.53----
Comprehensive Income & Other
-1,267-644.61-191.59-203.85197.974.85
Shareholders' Equity
39,20437,16135,49431,31128,85026,992
Total Liabilities & Equity
60,43957,79544,27540,93236,90134,469

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
14,96814,5052,9644,6634,3794,436
Net Cash (Debt)
469.97113.0114,67610,2649,3178,701
Net Cash Growth
-96.68%-99.23%42.98%10.17%7.07%-20.97%
Net Cash Per Share
33.338.011020.31713.81647.93605.15
Filing Date Shares Outstanding
14.1714.0614.3814.3814.3814.38
Total Common Shares Outstanding
14.1714.0614.3814.3814.3814.38
Working Capital
20,24918,33223,67116,36518,21916,968
Book Value Per Share
2766.252643.382468.502177.602006.391877.21
Tangible Book Value
38,96836,95935,36331,28028,78526,891
Tangible Book Value Per Share
2749.562629.012459.362175.442001.921870.18
Land
7,5547,5541,5571,557-1,557
Buildings
9,0689,0682,9742,974-2,974
Machinery
3,1183,0442,7342,502-2,001
Construction In Progress
2,8342,7862,3382,278--